MedPath

Inhibitory effects of dietary soy and whey proteins on muscle atrophy

Not Applicable
Conditions
muscle atrophy
Registration Number
JPRN-UMIN000028022
Lead Sponsor
Department of Nutritional Physiology, Institute of Biomedical Sciences, Tokushima University Graduate School
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with muscle diseases, chronic kidney diseases, diabetes, steroid treatment, allergy against soy or whey protein Patients getting supplement of soy-derived foods Pregnant women Patients with pace maker Patients with claustrophobia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We will give whey protein (8 g/day) or whey + soy proteins (8 g/day) to bed-ridden patients with PS 2 or 3 for 28 days. We will measure the volume and strength of quadriceps muscles.
Secondary Outcome Measures
NameTimeMethod
We will also measure urinary amounts of 8OHDG and 3-methylhistidine.
© Copyright 2025. All Rights Reserved by MedPath